查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1922525

日本再生医学市场报告：按类型、应用、最终用户和地区划分（2026-2034年）

Japan Regenerative Medicine Market Report by Type, Application, End User, and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格
简介目录

日本再生医学市场在2025年达到94亿美元。展望未来，IMARC集团预测，到2034年，该市场将达到235亿美元，2026年至2034年的复合年增长率为10.67%。推动市场成长的因素有很多，包括人们对移植排斥反应的日益关注、对使用再生医学进行整形外科治疗的需求不断增长、对牙科再生医学的关注度提高以及用于创伤治疗的药物使用量不断增加。

再生医学是生物医学领域一个极具发展前景的分支，专注于修復受损组织和器官。它涉及将实验室培养的干细胞安全地植入体内，以促进包括骨骼、软骨、血管和主要器官在内的各种身体组成的再生。这种综合方法涵盖了多种基于细胞和非细胞的再生疗法，并融合了免疫调节和组织工程等技术。除了在组织修復方面的作用外，再生医学在治疗阿兹海默症、帕金森氏症、心血管疾病、骨质疏鬆症和脊髓损伤等疑难杂症方面也展现出巨大的潜力。不断深入的研究为创新治疗方法带来了乐观的前景，这些疗法有望显着改善患者的生活品质和医疗效果。

日本再生医学市场的发展趋势：

日本再生医学市场正经历显着成长，这主要归因于人口老化的加剧。人口老化与糖尿病、心臟病和骨关节炎等慢性疾病发病率的上升密切相关，大大推动了市场扩张。此外，干细胞疗法和基因工程研究的日益普及也推动了再生医学领域的创新。干细胞和其他细胞疗法在组织再生和修復方面的广泛应用也进一步促进了市场发展。尤其值得一提的是，政府对再生医学研发的资金和监管支持，支撑了市场的强劲成长。生物技术的不断进步使得更精准、更有效的再生疗法得以开发，进一步促进了市场成长。此外，患者对再生医学治疗方法的认知度不断提高，也成为市场扩张的另一个催化剂。癌症发生率的上升以及对更有效率、更人性化治疗方法方案的探索，推动了癌症治疗领域对再生医学的需求，并在市场成长中发挥关键作用。

本报告解答的关键问题

  • 1. 日本再生医学市场规模有多大？
  • 2. 日本再生医学市场的前景如何？
  • 3.哪些因素正在推动日本再生医学市场的成长？

目录

第一章：序言

第二章：调查范围与调查方法

  • 调查目标
  • 相关利益者
  • 数据来源
  • 市场估值
  • 调查方法

第三章执行摘要

第四章：日本再生医学市场－引言

  • 概述
  • 市场动态
  • 产业趋势
  • 竞争资讯

第五章 日本再生医学市场概述

  • 过去和当前的市场趋势（2020-2025）
  • 市场预测（2026-2034）

第六章：日本再生医学市场－按类型细分

  • 干细胞疗法
  • 生物材料
  • 组织工程
  • 其他的

第七章 日本再生医学市场－依应用领域细分

  • 骨移植替代物
  • 骨骼和关节疾病
  • 皮肤科
  • 循环系统
  • 中枢神经系统
  • 其他的

第八章：日本再生医学市场－依最终用户细分

  • 医院
  • 专科诊所
  • 其他的

第九章：日本再生医学市场：依地区划分

  • 关东地区
  • 关西、近畿地区
  • 中部地区
  • 九州和冲绳地区
  • 东北部地区
  • 中国地区
  • 北海道地区
  • 四国地区

第十章：日本再生医学市场：竞争格局

  • 概述
  • 市场结构
  • 市场公司定位
  • 关键成功策略
  • 竞争对手仪錶板
  • 企业估值象限

第十一章主要企业概况

第十二章：日本再生医学市场：产业分析

  • 驱动因素、限制因素和机会
  • 波特五力分析
  • 价值链分析

第十三章附录

简介目录
Product Code: SR112026A19898

Japan regenerative medicine market size reached USD 9.4 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 23.5 Billion by 2034, exhibiting a growth rate (CAGR) of 10.67% during 2026-2034. The market is being driven by a range of factors, including heightened worries about transplant rejection, a greater need for regenerative orthopedic treatments, an increasing focus on dental regeneration, and the growing utilization of medicine for wound healing.

Access the full market insights report Request Sample

Regenerative medicine is an auspicious field within biomedical science that focuses on repairing damaged tissues and organs. It involves the use of laboratory-cultivated stem cells, which are safely transplanted into the body to encourage the regeneration of various bodily components such as bones, cartilage, blood vessels, and essential organs. This comprehensive approach includes a variety of regenerative therapies, both cellular and acellular, incorporating techniques like immunomodulation and tissue engineering. Apart from its role in tissue repair, regenerative medicine shows great promise in addressing persistent conditions such as Alzheimer's, Parkinson's, cardiovascular diseases (CVDs), osteoporosis, and spinal cord injuries. As research progresses, it presents an optimistic outlook for revolutionary treatments that have the potential to significantly enhance patients' quality of life and overall healthcare outcomes.

JAPAN REGENERATIVE MEDICINE MARKET TRENDS:

The Japan regenerative medicine market is experiencing substantial growth primarily due to the expanding elderly population. This demographic shift correlates with a heightened incidence of chronic ailments like diabetes, heart disease, and osteoarthritis, thus significantly contributing to the market's expansion. Moreover, the increasing focus on stem cell therapies and genetic engineering research is fostering innovation within the realm of regenerative medicine. The market is further stimulated by the growing utilization of stem cells and other cell-based therapies for the purpose of tissue regeneration and repair. Notably, the positive trajectory of the market is sustained by the allocation of funding and regulatory support for the advancement of regenerative medicine research and development. The continual advancements in biotechnology are facilitating the development of more precise and efficacious regenerative therapies, thereby bolstering the market's growth. Additionally, the rising awareness among patients regarding the availability of regenerative treatment options is serving as an additional catalyst for market expansion. The increasing occurrence of cancer and the quest for treatments that are both more efficient and accommodating for patients are driving the need for regenerative medicine in cancer treatment, playing a substantial role in the growth of the market.

JAPAN REGENERATIVE MEDICINE MARKET SEGMENTATION:

Type Insights:

  • To get detailed segment analysis of this market Request Sample
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others
  • Stem Cell Therapy
  • Biomaterial
  • Tissue Engineering
  • Others

Application Insights:

  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others
  • Bone Graft Substitutes
  • Osteoarticular Diseases
  • Dermatology
  • Cardiovascular
  • Central Nervous System
  • Others

End User Insights:

  • Hospitals
  • Specialty Clinics
  • Others
  • Hospitals
  • Specialty Clinics
  • Others

Regional Insights:

  • To get detailed regional analysis of this market Request Sample
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • Kanto Region
  • Kansai/Kinki Region
  • Central/ Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the regenerative medicine market in Japan?

2. What is the forecast for the regenerative medicine market in Japan?

3. What factors are driving the growth of the Japan regenerative medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Regenerative Medicine Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Regenerative Medicine Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Regenerative Medicine Market - Breakup by Type

  • 6.1 Stem Cell Therapy
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Biomaterial
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Tissue Engineering
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Others
    • 6.4.1 Historical and Current Market Trends (2020-2025)
    • 6.4.2 Market Forecast (2026-2034)

7 Japan Regenerative Medicine Market - Breakup by Application

  • 7.1 Bone Graft Substitutes
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Osteoarticular Diseases
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Dermatology
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Cardiovascular
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Central Nervous System
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)
  • 7.6 Others
    • 7.6.1 Historical and Current Market Trends (2020-2025)
    • 7.6.2 Market Forecast (2026-2034)

8 Japan Regenerative Medicine Market - Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Specialty Clinics
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Others
    • 8.3.1 Historical and Current Market Trends (2020-2025)
    • 8.3.2 Market Forecast (2026-2034)

9 Japan Regenerative Medicine Market - Breakup by Region

  • 9.1 Kanto Region
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Breakup by Type
    • 9.1.4 Market Breakup by Application
    • 9.1.5 Market Breakup by End User
    • 9.1.6 Key Players
    • 9.1.7 Market Forecast (2026-2034)
  • 9.2 Kansai/Kinki Region
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Breakup by Type
    • 9.2.4 Market Breakup by Application
    • 9.2.5 Market Breakup by End User
    • 9.2.6 Key Players
    • 9.2.7 Market Forecast (2026-2034)
  • 9.3 Central/ Chubu Region
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Breakup by Type
    • 9.3.4 Market Breakup by Application
    • 9.3.5 Market Breakup by End User
    • 9.3.6 Key Players
    • 9.3.7 Market Forecast (2026-2034)
  • 9.4 Kyushu-Okinawa Region
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Breakup by Type
    • 9.4.4 Market Breakup by Application
    • 9.4.5 Market Breakup by End User
    • 9.4.6 Key Players
    • 9.4.7 Market Forecast (2026-2034)
  • 9.5 Tohoku Region
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Breakup by Type
    • 9.5.4 Market Breakup by Application
    • 9.5.5 Market Breakup by End User
    • 9.5.6 Key Players
    • 9.5.7 Market Forecast (2026-2034)
  • 9.6 Chugoku Region
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2020-2025)
    • 9.6.3 Market Breakup by Type
    • 9.6.4 Market Breakup by Application
    • 9.6.5 Market Breakup by End User
    • 9.6.6 Key Players
    • 9.6.7 Market Forecast (2026-2034)
  • 9.7 Hokkaido Region
    • 9.7.1 Overview
    • 9.7.2 Historical and Current Market Trends (2020-2025)
    • 9.7.3 Market Breakup by Type
    • 9.7.4 Market Breakup by Application
    • 9.7.5 Market Breakup by End User
    • 9.7.6 Key Players
    • 9.7.7 Market Forecast (2026-2034)
  • 9.8 Shikoku Region
    • 9.8.1 Overview
    • 9.8.2 Historical and Current Market Trends (2020-2025)
    • 9.8.3 Market Breakup by Type
    • 9.8.4 Market Breakup by Application
    • 9.8.5 Market Breakup by End User
    • 9.8.6 Key Players
    • 9.8.7 Market Forecast (2026-2034)

10 Japan Regenerative Medicine Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Regenerative Medicine Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix